EMA/PE/0000228283
Submitted by Anonymous (not verified) on 3 March 2026 - 15:36
EMA/PE/0000228283
EMA/PE/0000228283
Ifosfamide
Cyclophosphamide
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 20 January 2026, 09:30 (CET) to 20 January 2026, 13:00 (CET)
EMA/PE/0000226753
Human medicines: highlights of 2022
Human medicines highlights 2022
Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Aqneursa, L-acetylleucine, Date of authorisation: 19/01/2026, Revision: 1, Status: Authorised
Scientific Explorer - Frequently Asked Questions